UNILAVA CORPORATION (OTC BB: UNLA.OB)

I love small caps…most of them are “story deals” and claim to have the next, newest, greatest thing, technology or gold reserves.  Today’s pick has some of that buzz, but is actually an operating company that could be a small cap supernova.  Trading for around 2 cents with a reasonable float (around 47MM shares), this could be a a great speculative trade.  I think it should be on the small cap trader’s radar.

Unilava Corporation (UNLA) is a company that is in the telecom space (all over the telecom space, in fact).  It has a grab bag of businesses (online Yellow Page advertising, communication services, owns and operates cellular towers, providing long distance phone service, mobile advertising services, etc.) that gave the company top-line revenues to over $5MM in 2010 (down from $7MM in 2009).

The play for me is in the future of UNLA.  If it continues to limp along with its current bag of businesses, it is not an interesting stock to play.  However, the company is on an acquisition binge that will, most likely, change the face of the company .

The company has announced LOI’s on several acquisitions over the past few months (HEXA2 and China Dragon Telecom).  Talking with the company tells me these acquisitions are for real and there will be a number more in the months to come.  These are all revenue/income producing businesses that have great potential (according to the company).  UNLA’s strategic relationship with China WiMax (CHWM) is still PR fluff, but it could be beneficial to the company if they can begin to execute on their plans.  All of this is in the public record….look at Yahoo! Finance for more detail.

I am in the process of getting interview with key players in this little drama (CEO of Unilava, CEO’s of the companies to be acquired, etc..) and will let you know more once I know more.

Taking a look at the chart

The chart for UNLA is not especially strong.  You can see days with strong volume followed by several days of no volume.  I would like to see the company do some “responsible” promotion in conjunction with positive news and get this stock more visibility to retail investors.  They need to get someone doing IR that actually returns phone calls (a pet peeve of mine).

Support is at the $.015 level with resistance between $0.275 and $.03.   The 52-week high was around $.60 (April of 2010), but the stock shows no indication of going back to those levels….yet.

Bottom Line

UNLA is a high risk/high reward play.  I am doing more research on the company which I will share in future blogs.  I bought shares in the company at current levels and think this could be a nice little gainer for me (if they can execute on their acquisition strategy and get the market to care).

I will keep you posted.  In the meantime, do your own due diligence.

Disclosure: Long UNLA

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or ”penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Zhone Technologies Inc. (ZHNE)

I am looking at a chart play on Zhone Technologies, Inc.  The company is in the VOIP equipment business and while last quarter was not so hot, management is maintaining its full-year guidance going forward.  Shipments (hence sales) not made last quarter due to adverse weather conditions will be made in the current quarter according to management.  Cash is strong and debt is manageable.  Based on current sales, they are turning their inventory, on average, once a quarter.  I would like to see that turnover pick up and better management of inventory, but it is acceptable for now.  They are still posting minor losses quarterly and annually, but long term prospects look good.  I would like to see some buyout rumors start on this one to really drive the stock.  The boards are buzzing with rumors about a possible buyout.

According to Yahoo! Finance this is what ZHNE does:

Zhone, together with its subsidiaries, designs, develops, and manufactures communications network equipment for telecommunications, wireless, and cable operators worldwide. It offers single line multi-service (SLMS) architecture, which provides support for voice over Internet protocol (VoIP) and IP entertainment by integrating access, transport, customer premises equipment, and management functions in a standards-based system. …………  sells its products to network service providers that offer voice, data, and video services to businesses, governments, utilities, and residential consumers, as well as telecommunications carriers. The company offers its products and services through channel partners, which include distributors, resellers, system integrators, and service providers. Zhone Technologies, Inc. was founded in 1999 and is headquartered in Oakland, California.

Taking a look at the Chart:

I deliberately ran some short-term indicators on this stock.  The stock is trading near a range that has been support in the past and appears to be acting that way again.  The bearish MACD momentum has disappeared and with the MACD line in position for a cross, this could be a good stock to watch.  Stochastics are improving (higher highs, higher lows) and the stochastics line has crossed over its signal line.  Volume has tailed off slightly, but look for any good news or some buying to help this stock run.

Bottom Line

Zhone is a safe play imo.  The company has a decent balance sheet, is flirting with profitability and is in a growing and vibrant market.  They are not the market leader and that is why I think that a buyout is a definite possibility.  I can never say when and if a buyout would occur, but I am watching this one.  The stock looks to be in a strong support level for the stock and could rebound off of these levels.  Resistance on the way up look like $2.35, $2.55 and the recent high (around $2.80).  Support is $2.14 and $2.20.

Definitely a good radar play.

Thanks,

Jeffrey Dean

Editor

Claude Resources, Inc. (CGR)

I came across a relatively unknown gold play called Claude Resources, Inc. (CGR).  I have done my research and I think that it is worth taking a look at.

It is a producing gold mine with some very interesting development and exploration properties.   You can do more DD from their excellent website.

Here is an financial abstract from their latest PR

Financial Highlights:

Very impressive!

A look at the Chart

I loaded the chart with all manner of indicators and overlays to see what I can come up with.  There are some indications the stock is completing the right shoulder on a “head and shoulders” pattern.  It is not a classic setup, but it might have some relevance to CGR.  It also appears their is some bullish pressure on the stock:  It is bouncing off of the bottom bollinger band (which could mean the move is to $2.71), the MACD has lost its bearish momentum and is approaching the “o” line, Stochastics are oversold, accum/dist is positive, etc…

Bottom Line:

CGR is a real company.  With their recent $50 MM equity raise, profitable operations, promising exploration efforts…..I think CGR could be a winner for my members.  The one negative I have on them is their capital structure.  They have a large number of shares outstanding (not an obscene amount), but still a large number.  If they continue to be profitable, I would like to see them do a buyback.  A reverse split would be lethal to the stock…they must know that.

Here is what I am looking at for CGR:

Last Close:              $2.38
Short Term Sell:   $2.71ish
Long Term Sell:     $3.00+ (if it can break and hold above the top bollinger band)
Good Luck and Great Trading,

Jeffrey Dean

Disclosure: No Positions

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Adamis Pharmaceuticals Corp. (ADMP.OB)

I continue to be sold on Adamis Pharmaceuticals Corp. (ADMP.OB).  It is a stock that I had called a “potential 10-Bagger” in a blog several months ago (read it here).  Unfortunately, the stock did little to make me look like a genius.  The stock has traded in a range between $0.25 (where I recommended it) and $0.30.  The stock continued to be beset by naked shorters.  In fact, Friday’s FINRA report was the first time since I began covering this stock that there was no shorting!

Finally!  The Financing News!

Last week, the company finally released the news that loyal ADMP holders have been waiting for:  A financing in the amount of $10,000,000!

Here is a summary of the financing:  Eses Holdings Limited, a company located in the United Arab Emirates has agreed to invest $10 million and acquire 40 million shares of Adamis common stock at a purchase price of $0.25 per share. $5 million of the investment was made at an initial closing. The remaining $5 million is to be invested in two tranches of $2.5 million each upon the achievement by the company of certain milestones. The company anticipates that the milestones will be achieved and the additional investments will occur within the next 60 to 120 days.

According to my contacts, the contingencies will be met in a timely manner, so ADMP will have what could be the last financing they will ever need….according to Dennis Carlo, CEO of Adamis.  The other notable thing about the financing was the their were NO warrants attached.  Dilution, yes, but no warrants which I see as a good sign.  The strike price of $0.25 was reasonable based upon recent trades although that did cause some downward pressure on the shares late in the week.

There is still time to get in!  A look at the chart!

The boards that I frequent are not shy of opinions on ADMP.  Most posters are highly skeptical of management due to the number of unfulfilled promises from management (Epi Pen Debacle, botched LaJolla Pharma merger, no financing news forever, etc…). The chart show the tug of war that is going on with the stock.  Pro-ADMP posters can’t wait for the short squeeze to start.  With all of the shorting activity, the % short could be very high.  Management still has a DNDN-type of success story in mind.  I have heard from others that the company will really begin to pick up steam in the near term. Let’s hope so.

I’ll apologize in advance…

…for  a long, boring paragraph about the tech behind their main drugs.  The blockbuster drug potential is contained in the APC compounds which are targeting the most prevalent type of cancer in men:  Prostrate Cancer.  My IR contact for ADMP created an overview of this drug family and I am going to repeat it in its entirety.

Contrasting the science of Dendreon (DNDN) to the science of Adamis (ADMP) does a good job of explaining why Adamis Pharmaceuticals (ADMP) could present a remarkably opportunity for investors.

Dendreon & Adamis Pharmaceuticals have both developed a novel method of attacking Prostate Cancer. Cancer behaves similarly to the viruses (Colds & Flu) we are all familiar with, invading a human cell and turning the cell into a manufacturing plant for more viruses or Cancer cells. Thousands of years of Evolution have produced an Immune System that readily handles most of Nature’s viruses. The body uses T-Cells for this task of dealing with viruses. T-cells can peer inside a cell and find the chemical fingerprint which identifies the cells carrying the virus. Cancer cells however, are not recognized by the immune system. Both Adamis & Dendreon have developed science to allow the immune system to create T-Cells specific against Prostate Cancer.

Dendreon has already proven this T-Cell approach works and is potentially a game changing breakthrough for the treatment of Prostate Cancer. Investors have seen shares of Dendreon rise on this promise with a high of $57 earlier this year after receiving FDA approval and currently trading around $36. Dendreon uses Dendritic cells to mount a T-Cell immune response against Prostate Cancer cells. While partially effective, Dendritic cells offer only a short antigen presentation window to create T-Cells over a period of a few hours. The numbers of T-Cells created are time limited, explaining why Dendreon enjoyed limited trial success but still enough to garner FDA approval based on the increase in patient longevity of 4.1 months. Dendron’s approach is costly to implement, running approximately $90,000 per patient. The process is complicated, must be done on a case by case basis and requires highly skilled technicians.

Adamis on the other hand is a relatively unknown company by investors, whose shares are currently trading for around 25 cents and still needs to conduct both an FDA Phase II and a Phase III trial. Adamis  also produces T-Cells, differing from Dendreon by using a Tolomerase gene vaccine. This has the advantage of longer antigen presentation cycle to create active T-Cells against Prostate Cancer. This longer presentation window (4 – 5 days) means the Adamis vaccine creates more T-Cells, which are the active ingredient that kill Cancer cells.

More importantly, the Adamis vaccine creates T-Cells which can target Prostate Cancer stem cells. These stem cells are the key to enabling Cancer to spread throughout the body. The Adamis T-Cells directly target these key cells while the Dendreon doesn’t.

Adamis will be launching a phase II trial shortly, which will run a year. Dennis Carlo (CEO of Adamis) says he’ll have actionable data in 6 months (proof it works) allowing Adamis to partner with a large Pharmaceutical company like Merck. Once the Phase II trial is concluded Adamis will still need to run a phase III trial, before they can apply for FDA approval. Given the similarity in science to Dendreon’s, it might be reasonable to assume Adamis could also be granted FDA approval.

The point to stress here is simply that Adamis is causing T-Cells to be produced that are active against Cancer cells, just like Dendreon. The difference is that Adamis’s vaccine produce more of them and targets Cancer stem cells and offers a simpler less expensive therapy. Adamis’s CEO, Dennis Carlo told me nearly a year ago, that he believed this held the promise as a potential Cancer cure. While that bold assertion remains to be proven, when the Street finally understands how big of a breakthrough this might be, investors could be well rewarded.

Why is ADMP a Ten-bagger? -or- ADMP:  From the outhouse to the penthouse

When I stumbled across ADMP, I did my usual in-depth research and actually got to talk to the CEO, head IR guy and a number of other interested parties.  I don’t think that the company has done a good enough job getting the word out about the company, but it appears that the good news is there.  With the blockbuster drug potential of the APC compounds (see previous paragraph), that alone could drive the company forward.  But, ADMP has the Epi-Pen product that has great potential and the Contraceptive Gel product (nearing approval) that could winners for the company.  I would like to see Dr. Carlo be more proactive in getting news out to the investing community and then following up on that news with updates periodically.

The DNDN connection obviously draws attention to ADMP’s potential.  I am impatient to see just how ADMP executes on its plan…and, realizes its potential.  Right now, long-term investors feel a little like they are in the “outhouse”, but there is a great deal of confidence that this stock is headed for the “penthouse”

Here is what I am looking at for entry/exit points

Last Close:              $0.26
Buy Opinion:          $0.25- $0.35
Short Term Sell:   $1.45  (I plan on selling enough to cover my investment, lock in a little profit and then sit back for the ride)
Long Term Sell:     $2.50+ (I plan on selling enough to cover my investment, lock in a little profit and then sit back for the ride)

Good Luck and Great Trading,

Jeffrey Dean

Disclosure:  Long ADMP

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stock market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

—————————————————————————————————————————————

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

American Power Corporation (TGMP)

I came across this heavily promoted stock late this afternoon and the hype and chart are telling me that American Power Corporation (TGMP) is ready for a fall.  It may not be today, but soon it will be heading south.

I won’t spend a great deal of time talking about TGMP, because there isn’t a lot to talk about.  This is a natural resource play (coal) that is being plastered all over the boards and is appearing in over 10 newsletters.  It has only been actively trading for a few days and has seen some strong volume and some decent price appreciation.  It has no revenues, no assets and only one recent PR of note.  That PR talks about the purchase of land in Montana for a coal plant.  I have, however, seen no news on how they are going to finance such a large project.  The company is so new they don’t even have a website.

Highly suspect!

Here is the chart…so you can see for yourself.

Volume is tailing off and a stock can only be pumped so much.  I expect to see TGMP fall…the question is when.  Be on the lookout.  The overall trend is still positive (Bullish MACD and stochastics near overbought levels) and who knows what additional promotion is “coming down the pike” that could drive the price even higher.

But….TGMP could fall and fall far.  If you are able to pick up 20 cents in its pending collapse, then you have made a great trade.

Here is what I am looking at for entry/exit points

Last Close:              $1.03

Short Opinion:      $1.00 – $1.10

Short Term Sell:    $0.90

Long Term Sell:     Between $0.70 and $0.80 (don’t be greedy…I don’t know how low it will go, but take your profit and run)

Good Luck and Great Trading,

Jeffrey Dean

Editor’s Note: I was checking emails the day after I wrote this blog and I received another email on TGMP that says “Warren Buffett to take over TGMP in two months”.  Despite the laughable headline that has no basis in fact, be sure and watch out that you don’t get short squeezed on this one.  THE PUMP LIVES!

Editors’s Note II:  It has been several days since my original post and TGMP continues its run.  It looks like the stock is finally cracking (9/2/10), so be ready to play.

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stock market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

—————————————————————————————————————————————

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Global Cash Access Holdings, Inc. (GCA)

A few weeks back, I came across Global Cash Access Holdings, Inc. (GCA) on one of my trips around the web, researched it, liked it….and then discarded it.  The stock was in a serious tailspin and I never like “falling-knife” stocks.  We all know those don’t usually end well.

But, it appears that the stock may have put in a bottom and the indicators are giving some credence to a rally.  It is a stock that given a longer time horizon might make for a good trade.  The stock is strong financially and after the hysteria about losing a big customer subsides, GCA could come back strong.

GCA (website) is a leading provider of cash access products and related services to over 1,100 casinos and other gaming properties in the United States, Europe, Canada, the Caribbean, Central America and Asia. GCA’s products and services provide gaming patrons access to cash through a variety of methods, including ATM cash withdrawals, point-of-sale debit card transactions, credit card cash advances, check verification and warranty services, and Western Union money transfers.

Why do I hate GCA? The few times I have been to a casino and needed extra cash, the exorbitant fees that companies like GCA charge tick me off.  I know they have to “make a buck”, but am too cheap to want to pay those fees.   However, that doesn’t stop them from making huge bucks from those fees to millions of willing customers.

The Fundamentals

GCA has strong fundamentals and that gives me confidence they have the ability to weather this downturn in their stock.  While L-T debt is high ($249MM), cash position and receivables are strong.  The company has good ratios and debt coverage is strong.  Cash flow continues to be strong.

The company is strongly profitable (although losing Harrah’s Casino at 14% of their overall business will hurt going forward).  Sales have plateaued during these tough economic times…which in some ways is a coup for the company.  They have maintained strong sales, margins and profitability during some difficult economic times.

The Chart

The Wild Card

Earnings are scheduled to be released Wednesday, August 4th.  I have read the analyst’s estimates and there appears to be no trepidation on the part of analysts.  We will see once earnings are released.  I have made the mistake of buying in anticipation of earnings and I don’t want you to make the same mistake.  We will see what happens once earnings are released.

Here is what I am looking at for entry/exit points

Last Close:              $4.35

Buy Opinion:          $4.00-4.75

Short Term Sell:   $6.00

Long Term Sell:     $8.00 and above

Good Luck and Great Trading,

Jeffrey Dean

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average trader is aware of them.

—————————————————————————————————————————————

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

EMIS, SREH, NVNC, LBSR, GSPG, AMEH, VIVK, SECI, CBAI, GRMC

AEN, ACTC, ANX

Good Morning Traders!

I have three quick charts for you to look at this morning on three penny stock biotech plays.  ACTC and ANX have charts that look like they are definitely on the move (up, that is) and the third AEN might be following them.

Advanced Cell Technology Inc. (ACTC.OB)

Adventrx Pharmaceuticals, Inc. (ANX)

Adeona Pharmaceuticals, Inc. (AEN)

Three stocks that you should get to know this morning.  They are all typical biotech plays with lousy balance sheets, marginal revenues and a great deal of uncertainty about their drugs. Any news could send them flying (in either direction).  Trade carefully, but all three might have some gains in them near term imo.

Be sure and sign up for my HOT penny stock alerts. I do all of the hard work to give you trading ideas that you can make money on.  My track record has been quite impressive. sign up here

Good luck and good trading,
Jeffrey Dean

Editor-in-Chief

FROI, NTMG, TADF, VASO, EXPU, GNOLF, CBIS, ECOB, GLER, LMCO

Fero Industries Inc (OTC: FROI) is up 6.52% to $0.245 on above-average volume. The company has announced that it has retained key personnel to assist in the due diligence and the acquisition of Sucanon® from Gvest. (OTC:FROI), (FROI)

While up early, FROI closed the day down 28%.  FROI has no revenues, no assets and, without the Sucanon acquisition closing, no reason to care.

The Sucanon acquisition sounds promising, but the PR was vague as to the revenues for the acquisition and the cost to FROI.

NT Mining Corp. (PINK: NTMG) is up 13.27% $0.350 on a strong volume of 4.85 million shares. On Friday, the company reported that it has hired former Terra Mining Ltd. employee and engineer Hank Sanche as a consultant to the company. (PINK:NTMG), (NTMG)

Tactical Air Defense Services Inc. (OTC: TADF) is up 10.00% to $0.0176 on a strong volume of 63.64 million shares. (OTC:TADF), (TADF)

TADF is a stock that looks like it will be in play a lot over the weeks and months to come.  The stock offers a very intriguing story, but the question is how will that translate to revenues and profits.

I would continue to watch it going forward for opportunities to get back in.

Vasomedical Inc. (OTC: VASO) is up 87.33% to $0.281. The company has announced that its subsidiary, Vaso Healthcare, has signed a sales representative agreement with GE Healthcare. (OTC:VASO), (VASO)

VASO might have several days run in it with such good news.  Lost in the PR is the fact that VASO raised $5 MM in funding to finance this venture.  This could make (or break) the company.

Expert Group Inc. (OTC: EXPU) is down 11.11% to $0.0160 on above-average volume of 4.03 million shares. (OTC:EXPU), (EXPU)

Genoil Inc. (ADR) (OTC: GNOLF) is up 43.48% to $0.165. The company has announced updates on its sand decontamination & oil water separation technologies. (OTC:GNOLF), (GNOLF)

Cannabis Science Inc. (OTC: CBIS) is up 46.15% to $0.190. The company has announced that it has acquired 100% of a private company with two revenue producing operations. (OTC:CBIS), (CBIS)

EcoBlu Products Inc. (OTC: ECOB) is up 64.58% to $0.395 on above-average volume of 6.54 million shares. (OTC:ECOB), (ECOB)

Global Earth Energy Inc. (OTC: GLER) is up 50.00% to $0.0600 following the news that it has secured up to $10 million in equity financing. (OTC:GLER), (GLER)

Li-ion Motors Corp. (OTC: LMCO) is up 20.22% to $2.14. The company has announced that it will unveil its long awaited Inizio Supercar at an open house September 15, 2010. (OTC:LMCO), (LMCO)

Beacon Equity Group

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.  BlueWave Advisors has been compensated thirty five thousand dollars from Golden Dragon Media, Inc. (a non-controlling third party shareholder) for TADF advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

HEMA, FVRG, TGLN, VIVK, TADF, HOMS, RMLX, AMCG, CBAI, ELCR

AMOK, BSRC, MYNG, NUBL, LUXE, SNRS, GETA, WLSI, ZVTK

The following are penny stocks that made the news yesterday.  Some have given back yesterday’s gains already, but others might still be in play.  My comments are in quotation marks below each ticker.

Amarok Resources Inc. (OTC: AMOK) was up yesterday 13.85% to $1.48.  On Tuesday, the company announced that drilling is now underway on the Rodeo Creek project.  (OTC:AMOK), (AMOK)

I love the ticker for the company (running AMOK anyone?), but I don’t think much of the company or its chart.  It is in a holding pattern without any trend or momentum.  Next!

BioSolar Inc. (OTC: BSRC) is up 34.28% to $0.256 on strong volume of 6.21 million shares trading hands.  (OTC:BSRC), (BSRC)

The inevitable collapse today after two strong days.  I like BSRC’s long term prospects.  It will be interesting to see if they can turn this good news into a prolonged trend.  Might be a good stock to play on the dips.

Golden Eagle International Inc. (OTC: MYNG) was up 52.73% to $0.420.  (OTC: MYNG), (MYNG)

Get ready to short this puppy!  Up for the 6th day in a row, MYNG is going to collapse very soon.  Get ready!

Numobile Inc. (OTC: NUBL) is up 4.35% to $0.0024.  NuMobile and Nova Energy partnerships to be featured in China Crescent’s Trade Mission, which is scheduled to begin on May 24 in conjunction with World’s Fair in Shanghai.  (OTC:NUBL), (NUBL)

Onyx China Inc (OTC: LUXE) is up 30.59% to $0.0222 on above-average volume of 2.30 million shares, compared to average volume of 229,000 shares.  (OTC:LUXE), (LUXE)

Sunrise Consulting Group Inc. (PINK: SNRS) is up 66.67% to $0.0005 on an above-average volume of 751.79 million shares.  (PINK:SNRS), (SNRS)

This will crash soon, but good luck getting any shares to short.

Genta Inc. (OTC: GETA) is up 1.18% to $0.0513.  (OTC:GETA), (GETA)

GETA is just diluting the crap out of everyone.  It is going to be almost impossible to get these shares to rise unless they get some miracle.

Wellstar International Inc. (OTC: WLSI) remains unchanged at $0.0007 on above-average volume.  The company has reported that it has installed and trained the staff for the TMI Imaging system in a physician’s office in Torrance, California.  (OTC:WLSI), (WLSI)

Zevotek Inc. (OTC:ZVTK) is down 13.64% to $0.0019 on strong volume of 147.27 million shares trading hands.  (OTC: ZVTK), (ZVTK)

I have talked to the company several times and they claim they are not promoting or manipulating their own stock.  I tend to believe them.  ZVTK has been a creation of the message boards.  The relentless optimism of posters gave the public an idea that ZVTK had “turned the corner” and was going to post big numbers.  It didn’t happen and the stock continues to get hammered.

It is  not a time to go long on ZVTK.

Be sure and sign up for my penny stock alerts.  Go to my signup page and, once signed up, receive information on stocks that I think are going to move.

Thanks for stopping by,

Jeffrey Dean

Editor

DKS, AKNS, SPRD, HIBB, CAB, PFE, SINA, VVUS, MSFT, ABK

The following is a list of companies that are “in the news” today.  The two that I am most interested in are AKNS (winner!) and ABK (loser!).  They are both penny stocks that are going in different directions, but both could be a great trade.

I highly recommend that you sign up for my penny stock alerts.  I do all the “heavy lifting” and pick stocks from the pinks, bulletin boards and Nasdaq to share with my members.  The idea is to capture gains on stocks that are likely to move.  Just this past Monday, I posted a 38% gain on FLPC.  Profit takers took over today on FLPC, but I see more gains in the future.

Dick’s Sporting Goods Inc. (NYSE: DKS) is down 5.20% to $27.00 despite posting earnings that beat estimates. (NYSE:DKS), (DKS)

Akeena Solar Inc. (NASDAQ: AKNS) is up 11.83% to $1.04. The company on Monday announced it has entered into an exclusive worldwide agreement to manufacture, distribute, market and install its solar panels under the Westinghouse name. (NASDAQ:AKNS), (AKNS)

Their news about the Westinghouse deal could really catapult this company into the next echelon.  Solar panel manufacturers are beating each other over the head on a daily basis.  The Westinghouse name carries a great deal of clout and puts AKNS “above the fray”.  Read the PR by clicking here.

Spreadtrum Communications Inc. (NASDAQ: SPRD) is up 14.67% to $9.38. The company on Monday said it has swung to a profit for the Q1 as revenue came in better than expected at $52.1 million, versus the $40 million to $43 million estimate. (NASDAQ:SPRD), (SPRD)

Hibbett Sports Inc. (NASDAQ: HIBB) is down 0.90% to $27.57. Susquehanna has lifted its price target and maintained a ‘Positive’ rating on Hibbett Sports. (NASDAQ:HIBB), (HIBB)

Cabela’s Inc. (NYSE: CAB) is down 1.41% to $17.42. CAB levels to watch. (NYSE:CAB), (CAB)

Pfizer Inc. (NYSE: PFE) is up 0.32% to $16.16. The company has announced its plan to cut 6,000 jobs as part of the company’s on-going restructuring following its $68 billion takeover of rival Wyeth. (NYSE:PFE), (PFE)

SINA Corp. (USA) (NASDAQ: SINA) is up 8.18% to $37.70 following its earnings report Monday. Auriga has maintained a “Buy” and a price target of $51.00 following the results. (NASDAQ:SINA), (SINA)

VIVUS Inc. (NASDAQ: VVUS) is up 3.05% to $12.85. (NASDAQ:VVUS), (VVUS)

Microsoft Corp. (NASDAQ: MSFT) is down 1.42% to $28.53. The company has today previewed the new Windows Live Hotmail. (NASDAQ:MSFT), (MSFT)

Ambac Financial Group Inc. (NYSE: ABK) is down 13.70% to $1.26 following its Q1 results. The company posted a quarterly loss of $690 million, wider than the year-ago loss of $392 million. (NYSE:ABK), (ABK)

Enjoy and have a great trading day tomorrow!

Jeffrey Dean, Editor

—————————————————————————————————————————————–

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.